Response to comments on the Scientific Opinion of the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) on the scientific substantiation of health claims related to Lactobacillus casei strain Shirota and maintenance of the upper respiratory tract defence against pathogens by maintaining immune defences pursuant to Article 13.5 of Regulation (EC) No 1924/2006
Meta data
Keywords
Lactobacillus casei, fermented milk product, upper respiratory tract infections, health claims, comments
On request from
European Commission
Question Number
EFSA-Q-2011-00153
Contact
Abstract
No abstract available
© European Food Safety Authority, 2011